Search Results 1161-1170 of 14817 for anti-TNF drugs
Etranacogene dezaparvovec-drlb injection is used to treat hemophilia B (congenital Factor IX deficiency) in patients who are using Factor IX treatment, have ...
... anti-TNF agents) within 2 weeks prior to initiation of study treatment: Participants who have received acute, low-dose, systemic immunosuppressant medications ...
Photodynamic therapy uses a drug, such as aminolevulinic acid hydrochloride, that becomes active when it is exposed to light. The activated drug may kill cancer ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or ...
Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Lonsurf. Descriptions. Trifluridine and tipiracil ...
... drug therapy. Pancreatic cancer has identifiable genetic (DNA) changes, yet for many it is not known whether these affect response to cancer drugs.
methotrexate [MTX]), immunomodulators, and/or tumor necrosis factor alpha (TNF-?) antagonist therapy (eg, infliximab, adalimumab). This includes ...
... treatment with either type of therapy in patients with metastatic anti-estrogen-resistant ER+ breast cancer. Participation eligibility. Participant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.